Intraperitoneal administration of marinobufagenin resulted in a reliable and dose-dependent suppression of ethanol self-administration in drug- and experimentally naive DBA/2 mice. The findings suggest that Na/K-ATPase contributes to both mediation of the ethanol reinforcing properties and the mood regulation.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Mechanism of Marinobufagenin-Induced Hyperpermeability of Human Brain Microvascular Endothelial Cell Monolayer: A Potential Pathogenesis of Seizure in Preeclampsia.
Cells
October 2024
Artemis Biotechnologies LLC, Temple, TX 76502, USA.
Preeclampsia (preE) is a hypertensive disorder in pregnancies. It is the third leading cause of mortality among pregnant women and fetuses worldwide, and there is much we have yet to learn about its pathophysiology. One complication includes cerebral edema, which causes a breach of the blood-brain barrier (BBB).
View Article and Find Full Text PDFRole of Na-K ATPase Alterations in the Development of Heart Failure.
Int J Mol Sci
October 2024
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University, 83232 Bratislava, Slovakia.
Article Synopsis
- - Na-K ATPase is crucial for heart function, consisting of three subunits that help transport sodium and potassium ions, maintaining the balance of these cations in heart cells and influencing heart contractions.
- - This enzyme also acts as a receptor for certain glycosides and steroids, regulating heart metabolism and cell survival, with its activity affected by various hormones through modifications of its associated protein, phospholemman.
- - In heart failure, Na-K ATPase activity can change in different ways, leading to either adaptive mechanisms for maintaining function or issues like calcium overload and arrhythmias, ultimately impacting heart health based on the enzyme's isoform composition and oxidative stress.
Antibody to Endogenous Cardiotonic Steroid Reverses Vascular Fibrosis and Restores Vasorelaxation in Chronic Kidney Disease.
Int J Mol Sci
August 2024
Padakonn Pharma, Puskini 9, 20309 Narva, Estonia.
Marinobufagenin (MBG) is implicated in chronic kidney disease, where it removes Fli1-induced inhibition of the collagen-1. We hypothesized that (i) in nephrectomized rats, aortic fibrosis develops due to elevated plasma MBG and inhibited Fli1, and (ii) that the antibody to MBG reduces collagen-1 and improves vasodilatation. A partial nephrectomy was performed in male Sprague-Dawley rats.
View Article and Find Full Text PDFPerioperative Marinobufagenin (MBG) Measurement May Improve Acute Kidney Injury Risk Assessment in Patients Undergoing Major Cardiac Surgery: A Proof-of-Concept Study.
Medicina (Kaunas)
June 2024
Department of Health Sciences, University "Magna Graecia" of Catanzaro, 88100 Catanzaro, Italy.
Acute kidney injury (AKI) remains a significant complication following major cardiac surgery. Marinobufagenin (MBG), a cardiotonic steroid involved in sodium balance and blood pressure regulation, has been linked to organ damage after ischemia-reperfusion events. This pilot, prospective study investigates the utility of circulating MBG to improve AKI risk assessment in cardiac surgery patients as a stand-alone biomarker and after inclusion in a validated risk model (STS-AKI score).
View Article and Find Full Text PDFEvaluation of the activity of cardiac glycosides on RORγ and RORγT nuclear receptors.
Arch Biochem Biophys
September 2024
Laboratory of Epigenetics, Institute of Medical Biology, Polish Academy of Sciences, 93-232, Lodz, Poland. Electronic address:
Cardiac glycosides, derived from plants and animals, have been recognized since ancient times. These substances hinder the function of the sodium-potassium pump within eukaryotic cells. Many reports have shown that these compounds influence the activity of nuclear receptors.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!